Patents by Inventor Timothy C. Dunn

Timothy C. Dunn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220000399
    Abstract: Systems, devices, and methods for detecting, measuring and classifying meals for an individual based on analyte measurements. These results and related information can be presented to the individual to show the individual which meals are causing the most severe analyte response. These results can be organized and categorized based on preselected criteria or previous meals and results so as to organize and present the results in a format with reference to glucose as the monitored analyte. Various embodiments disclosed herein relate to methods, systems, and software applications intended to engage an individual by providing direct and timely feedback regarding the individual's meal-related glycemic response.
    Type: Application
    Filed: June 28, 2021
    Publication date: January 6, 2022
    Inventors: Gary A. Hayter, Timothy C. Dunn, Yashesvini V. Ram, Claire A. Cunningham, Justin N. Williams, William Koo Lee
  • Publication number: 20210251576
    Abstract: A system and method provides a glucose report for determining glycemic risk based on an ambulatory glucose profile of glucose data over a time period, a glucose control assessment based on median and variability of glucose, and indicators of high glucose variability. Time of day periods are shown at which glucose levels can be seen. A median glucose goal and a low glucose line provide coupled with glucose variability provide a view into effects that raising or lowering the median goal would have. Likelihood of low glucose, median glucose compared to goal, and variability of glucose below median provide probabilities based on glucose data. Patterns can be seen and provide guidance for treatment.
    Type: Application
    Filed: December 15, 2020
    Publication date: August 19, 2021
    Inventors: Erwin S. Budiman, Gary A. Hayter, Kenneth J. Doniger, Timothy C. Dunn, Nathan C. Crouther, Glenn Berman, Howard A. Wolpert
  • Publication number: 20210225524
    Abstract: Systems, devices, and methods are provided that allow detection of episodes in analyte measurement, prompting a patient to self-report possible causes for the episodes. Correlation of possible causes with detected episodes assists patient behavior modification to reduce the occurrence of episodes.
    Type: Application
    Filed: April 9, 2021
    Publication date: July 22, 2021
    Inventors: Gary A. Hayter, Timothy C. Dunn, Nathan Crouther, Daniel M. Bernstein, Eric L. Davis
  • Publication number: 20210161438
    Abstract: Generally, methods of analyte monitoring management, and articles of manufacturing related thereto, are provided. The methods include receiving analyte measurement data and analyzing the analyte measurement data for health related parameters. Recommendations are determined for creating or modifying a treatment program based on the analysis, and provided within a user-interface that enables a user to create or modify the treatment program. Further, generally, methods of for managing analyte measurement data, and articles of manufacturing related thereto, are provided. The methods include receiving analyte measurement data that represent data collected over a time period, and analyzing the analyte measurement data for analyte episodes within that time period. Threshold based episodes and/or rate-of-change based episodes may be determined.
    Type: Application
    Filed: February 9, 2021
    Publication date: June 3, 2021
    Inventors: Nathan C. Crouther, Timothy C. Dunn
  • Patent number: 11017890
    Abstract: An analyte measurement system includes one or more handheld analyte meters and/or measurement devices and a means for collecting data, preserving data integrity, and uniquely identifying patient data received from multiple sources. For example, provided herein is a means to uniquely identify patients and their data when the data is collected from one or more measurement devices. By providing a way to allow the patients to use multiple sources to collect data, the system described herein provides patients with more flexibility, which should encourage better compliance to protocols. Further, by having a way to uniquely identify patients' data without requiring a patient to only use one analyte meter, for example, data can be centralized and analysis can be done with more assurance that all of the patient's data is being considered in the analyses.
    Type: Grant
    Filed: October 5, 2020
    Date of Patent: May 25, 2021
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Daniel M. Bernstein, Gary A. Hayter, Timothy C. Dunn, Mani Gopal, Eric Davis, Brittany K. Bradrick, Todd Winkler
  • Patent number: 11004566
    Abstract: Systems, devices, and methods are provided that allow detection of episodes in analyte measurement, prompting a patient to self-report possible causes for the episodes. Correlation of possible causes with detected episodes assists patient behavior modification to reduce the occurrence of episodes.
    Type: Grant
    Filed: July 5, 2016
    Date of Patent: May 11, 2021
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Gary A. Hayter, Timothy C. Dunn, Nathan Crouther, Daniel M. Bernstein, Eric L. Davis
  • Publication number: 20210100515
    Abstract: A system and method to provide guidance for diabetes therapy includes determining glycemic risks based on an analysis of glucose data. The analysis includes visualization of a glucose median, the variability of glucose in a patient, and the risk of hypoglycemia. An Advanced Daily Patterns report includes a visualization of an ambulatory glucose profile and a glucose control measure. The glucose control measure provides a highly visible and understandable display of the glucose condition of a patient visually expressed in the categories of low glucose, median glucose, and glucose variability.
    Type: Application
    Filed: December 15, 2020
    Publication date: April 8, 2021
    Inventors: Timothy C. Dunn, Kenneth J. Doniger, Glenn Berman, Gary A. Hayter, Erwin S. Budiman, Daniel M. Bernstein, Nathan Crouther
  • Publication number: 20210093251
    Abstract: Systems, devices, and methods for detecting, measuring and classifying meals for an individual based on analyte measurements. These results and related information can be presented to the individual to show the individual which meals are causing the most severe analyte response. These results can be organized and categorized based on preselected criteria or previous meals and results so as to organize and present the results in a format with reference to glucose as the monitored analyte. Various embodiments disclosed herein relate to methods, systems, and software applications intended to engage an individual by providing direct and timely feedback regarding the individual's meal-related glycemic response.
    Type: Application
    Filed: December 15, 2020
    Publication date: April 1, 2021
    Inventors: Gary A. Hayter, Timothy C. Dunn, Nathan Crouther
  • Publication number: 20210090737
    Abstract: Presented herein are one or more software applications to help a user manager their diabetes. Embodiments and descriptions of the various applications are provided below in conjunction with an analyte measurement device.
    Type: Application
    Filed: December 3, 2020
    Publication date: March 25, 2021
    Inventors: Daniel M. Bernstein, Kenneth J. Doniger, Timothy C. Dunn, Gary A. Hayter, Howard Wolpert
  • Patent number: 10945646
    Abstract: Generally, methods of analyte monitoring management, and articles of manufacturing related thereto, are provided. The methods include receiving analyte measurement data and analyzing the analyte measurement data for health related parameters. Recommendations are determined for creating or modifying a treatment program based on the analysis, and provided within a user-interface that enables a user to create or modify the treatment program. Further, generally, methods of for managing analyte measurement data, and articles of manufacturing related thereto, are provided. The methods include receiving analyte measurement data that represent data collected over a time period, and analyzing the analyte measurement data for analyte episodes within that time period. Threshold based episodes and/or rate-of-change based episodes may be determined.
    Type: Grant
    Filed: March 30, 2017
    Date of Patent: March 16, 2021
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Nathan C. Crouther, Timothy C. Dunn
  • Patent number: 10923218
    Abstract: An analyte measurement system includes one or more handheld analyte meters and/or measurement devices and a means for collecting data, preserving data integrity, and uniquely identifying patient data received from multiple sources. For example, provided herein is a means to uniquely identify patients and their data when the data is collected from one or more measurement devices. By providing a way to allow the patients to use multiple sources to collect data, the system described herein provides patients with more flexibility, which should encourage better compliance to protocols. Further, by having a way to uniquely identify patients' data without requiring a patient to only use one analyte meter, for example, data can be centralized and analysis can be done with more assurance that all of the patient's data is being considered in the analyses.
    Type: Grant
    Filed: July 1, 2020
    Date of Patent: February 16, 2021
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Daniel M. Bernstein, Gary A. Hayter, Timothy C. Dunn, Mani Gopal, Eric Davis, Brittany K. Bradrick, Todd Winkler
  • Publication number: 20210030323
    Abstract: Systems, devices, and methods for detecting, measuring and classifying meals for an individual based on analyte measurements. These results and related information can be presented to the individual to show the individual which meals are causing the most severe analyte response. These results can be organized and categorized based on preselected criteria or previous meals and results so as to organize and present the results in a format with reference to glucose as the monitored analyte. Various embodiments disclosed herein relate to methods, systems, and software applications intended to engage an individual by providing direct and timely feedback regarding the individual's meal-related glycemic response.
    Type: Application
    Filed: July 29, 2020
    Publication date: February 4, 2021
    Inventors: Gary A. Hayter, Timothy C. Dunn, Yashesvini V. Ram, Claire A. Cunningham, Justin N. Williams, William Koo Lee
  • Publication number: 20210020282
    Abstract: An analyte measurement system includes one or more handheld analyte meters and/or measurement devices and a means for collecting data, preserving data integrity, and uniquely identifying patient data received from multiple sources. For example, provided herein is a means to uniquely identify patients and their data when the data is collected from one or more measurement devices. By providing a way to allow the patients to use multiple sources to collect data, the system described herein provides patients with more flexibility, which should encourage better compliance to protocols. Further, by having a way to uniquely identify patients' data without requiring a patient to only use one analyte meter, for example, data can be centralized and analysis can be done with more assurance that all of the patient's data is being considered in the analyses.
    Type: Application
    Filed: October 5, 2020
    Publication date: January 21, 2021
    Inventors: Daniel M. Bernstein, Gary A. Hayter, Timothy C. Dunn, Mani Gopal, Eric Davis, Brittany K. Bradrick, Todd Winkler
  • Patent number: 10888272
    Abstract: Systems, devices, and methods for detecting, measuring and classifying meals for an individual based on analyte measurements. These results and related information can be presented to the individual to show the individual which meals are causing the most severe analyte response. These results can be organized and categorized based on preselected criteria or previous meals and results so as to organize and present the results in a format with reference to glucose as the monitored analyte. Various embodiments disclosed herein relate to methods, systems, and software applications intended to engage an individual by providing direct and timely feedback regarding the individual's meal-related glycemic response.
    Type: Grant
    Filed: July 8, 2016
    Date of Patent: January 12, 2021
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Gary A. Hayter, Timothy C. Dunn, Nathan Crouther
  • Patent number: 10872696
    Abstract: Presented herein are one or more software applications to help a user manager their diabetes. Embodiments and descriptions of the various applications are provided below in conjunction with an analyte measurement device.
    Type: Grant
    Filed: February 8, 2017
    Date of Patent: December 22, 2020
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Daniel M. Bernstein, Kenneth J. Doniger, Timothy C. Dunn, Gary A. Hayter, Howard Wolpert
  • Publication number: 20200357492
    Abstract: An analyte measurement system includes one or more handheld analyte meters and/or measurement devices and a means for collecting data, preserving data integrity, and uniquely identifying patient data received from multiple sources. For example, provided herein is a means to uniquely identify patients and their data when the data is collected from one or more measurement devices. By providing a way to allow the patients to use multiple sources to collect data, the system described herein provides patients with more flexibility, which should encourage better compliance to protocols. Further, by having a way to uniquely identify patients' data without requiring a patient to only use one analyte meter, for example, data can be centralized and analysis can be done with more assurance that all of the patient's data is being considered in the analyses.
    Type: Application
    Filed: July 1, 2020
    Publication date: November 12, 2020
    Inventors: Daniel M. Bernstein, Gary A. Hayter, Timothy C. Dunn, Mani Gopal, Eric Davis, Brittany K. Bradrick, Todd Winkler
  • Patent number: 10685749
    Abstract: Method and system including displaying a first representation of a medication treatment parameter profile, displaying a first representation of a physiological profile associated with the medication treatment parameter profile, detecting a modification to a segment of the medication treatment parameter profile, displaying a modified representation of the medication treatment parameter profile and the physiological profile based on the detected modification to the segment of the medication treatment parameter profile, modifying an attribute of the first representation of the medication treatment parameter profile, and modifying an attribute of the first representation of the physiological profile are provided.
    Type: Grant
    Filed: December 28, 2015
    Date of Patent: June 16, 2020
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary A. Hayter, Timothy C. Dunn
  • Publication number: 20200015756
    Abstract: A system and method to provide guidance for diabetes therapy includes determining glycemic risks based on an analysis of glucose data. The analysis includes visualization of a glucose median, the variability of glucose in a patient, and the risk of hypoglycemia. An Advanced Daily Patterns report includes a visualization of an ambulatory glucose profile and a glucose control measure. The glucose control measure provides a highly visible and understandable display of the glucose condition of a patient visually expressed in the categories of low glucose, median glucose, and glucose variability.
    Type: Application
    Filed: July 1, 2019
    Publication date: January 16, 2020
    Inventors: Timothy C. Dunn, Kenneth J. Doniger, Glenn Berman, Gary A. Hayter, Erwin S. Budiman, Daniel M. Bernstein, Nathan Crouther
  • Patent number: 10383580
    Abstract: A system and method to provide guidance for diabetes therapy includes determining glycemic risks based on an analysis of glucose data. The analysis includes visualization of a glucose median, the variability of glucose in a patient, and the risk of hypoglycemia. An Advanced Daily Patterns report includes a visualization of an ambulatory glucose profile and a glucose control measure. The glucose control measure provides a highly visible and understandable display of the glucose condition of a patient visually expressed in the categories of low glucose, median glucose, and glucose variability.
    Type: Grant
    Filed: December 31, 2013
    Date of Patent: August 20, 2019
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Timothy C. Dunn, Kenneth J. Doniger, Glenn Berman, Gary A. Hayter, Erwin S. Budiman, Daniel M. Bernstein, Nathan Crouther
  • Publication number: 20190183393
    Abstract: Analyte monitoring systems, devices, and methods associated with analyte monitoring devices, and devices incorporating the same are provided. Various graphical user interfaces (GUI) and navigation flows are provided for performing various features, activities, functions, etc., associated with the analyte monitoring device or system. Intuitive navigation is provided to enhance the interpretation of analyte measurements.
    Type: Application
    Filed: October 30, 2018
    Publication date: June 20, 2019
    Inventors: Marc B. Taub, Jai Karan, Annie C. Tan, Timothy C. Dunn, Joel M. Goldsmith, Christine M. Neuhaus, Stephen A. Rossi, Sujit R. Jangam